Assessing Immune Response to SARS-CoV-2 Infection

Overview

Journal Immunotargets Ther

Publisher Dove Medical Press

Specialty Allergy & Immunology

Date 2020 Jul 2

PMID 32607314

Citations 7

Authors

Michael R Shurin

Alison Morris

Alan Wells

Sarah E Wheeler

Affiliations

Soon will be listed here.

Citing Articles

Applying the digital data and the bioinformatics tools in SARS-CoV-2 research.

Tan M, Xia J, Luo H, Meng G, Zhu Z Comput Struct Biotechnol J. 2023; 21:4697-4705.

PMID: 37841328 PMC: 10568291. DOI: 10.1016/j.csbj.2023.09.044.

Effector-Memory B-Lymphocytes and Follicular Helper T-Lymphocytes as Central Players in the Immune Response in Vaccinated and Nonvaccinated Populations against SARS-CoV-2.

Islas-Vazquez L, Cruz-Aguilar M, Velazquez-Soto H, Jimenez-Corona A, Perez-Tapia S, Jimenez-Martinez M Vaccines (Basel). 2022; 10(10).

PMID: 36298626 PMC: 9607383. DOI: 10.3390/vaccines10101761.

Antibody Response of BNT162b2 and CoronaVac Platforms in Recovered Individuals Previously Infected by COVID-19 against SARS-CoV-2 Wild Type and Delta Variant.

Zhang R, Khong K, Leung K, Liu D, Fan Y, Lu L Vaccines (Basel). 2021; 9(12).

PMID: 34960189 PMC: 8705363. DOI: 10.3390/vaccines9121442.

ABO blood group association and COVID-19. COVID-19 susceptibility and severity: a review.

Shibeeb S, Khan A Hematol Transfus Cell Ther. 2021; 44(1):70-75.

PMID: 34541459 PMC: 8437766. DOI: 10.1016/j.htct.2021.07.006.

Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects.

Wheeler S, Shurin G, Yost M, Anderson A, Pinto L, Wells A Microbiol Spectr. 2021; 9(1):e0034121.

PMID: 34346750 PMC: 8552678. DOI: 10.1128/Spectrum.00341-21.

References

Zhang C, Shi L, Wang F . Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020; 5(5):428-430. PMC: 7129165. DOI: 10.1016/S2468-1253(20)30057-1. View

Estola T . Coronaviruses, a new group of animal RNA viruses. Avian Dis. 1970; 14(2):330-6. View

Thevarajan I, Nguyen T, Koutsakos M, Druce J, Caly L, van de Sandt C . Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med. 2020; 26(4):453-455. PMC: 7095036. DOI: 10.1038/s41591-020-0819-2. View

Ziegler C, Allon S, Nyquist S, Mbano I, Miao V, Tzouanas C . SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. Cell. 2020; 181(5):1016-1035.e19. PMC: 7252096. DOI: 10.1016/j.cell.2020.04.035. View

Al-Tawfiq J, Zumla A, Memish Z . Coronaviruses: severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus in travelers. Curr Opin Infect Dis. 2014; 27(5):411-7. DOI: 10.1097/QCO.0000000000000089. View

Kahn J, McIntosh K . History and recent advances in coronavirus discovery. Pediatr Infect Dis J. 2005; 24(11 Suppl):S223-7, discussion S226. DOI: 10.1097/01.inf.0000188166.17324.60. View

Jackson D, Busse W, Bacharier L, Kattan M, OConnor G, Wood R . Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020; 146(1):203-206.e3. PMC: 7175851. DOI: 10.1016/j.jaci.2020.04.009. View

Cyranoski D . Profile of a killer: the complex biology powering the coronavirus pandemic. Nature. 2020; 581(7806):22-26. DOI: 10.1038/d41586-020-01315-7. View

van der Hoek L . Human coronaviruses: what do they cause?. Antivir Ther. 2007; 12(4 Pt B):651-8. View

10.

Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S . SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181(2):271-280.e8. PMC: 7102627. DOI: 10.1016/j.cell.2020.02.052. View

11.

Yang Y, Shen C, Li J, Yuan J, Wei J, Huang F . Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J Allergy Clin Immunol. 2020; 146(1):119-127.e4. PMC: 7189843. DOI: 10.1016/j.jaci.2020.04.027. View

12.

Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X . COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020; 27(5):1451-1454. PMC: 7091918. DOI: 10.1038/s41418-020-0530-3. View

13.

Iwasaki A, Yang Y . The potential danger of suboptimal antibody responses in COVID-19. Nat Rev Immunol. 2020; 20(6):339-341. PMC: 7187142. DOI: 10.1038/s41577-020-0321-6. View

14.

de Wit E, van Doremalen N, Falzarano D, Munster V . SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016; 14(8):523-34. PMC: 7097822. DOI: 10.1038/nrmicro.2016.81. View

15.

Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L . Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19). Front Immunol. 2020; 11:827. PMC: 7205903. DOI: 10.3389/fimmu.2020.00827. View

16.

Cunningham A, Goh H, Koh D . Treatment of COVID-19: old tricks for new challenges. Crit Care. 2020; 24(1):91. PMC: 7076992. DOI: 10.1186/s13054-020-2818-6. View